Mangubat, Baby Girl .
HRN: 27-07-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2025
AMPICILLIN 250MG (VIAL)
05/02/2025
05/08/2025
IV
155mg
Q12
Newborn Affected By Maternal Factor
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes